Blood bank reagents and supplies
Ended Awarded Last action
- Contract number
- 36C25518N3253
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $61,508
Award facts
- Contract value 76% obligated
- $80,917.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Newtown, PA 18940, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,433 | |
| Funding Only Action | -$3,976 | |
| Funding Only Action | -$2,030 | |
| Funding Only Action | $910 | |
| Original award | $69,037 |
About this award
This federal contract award, with an ID of VA25515A0029|36C25518N3253, was issued by the Department of Veterans Affairs (VA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract is a Blanket Purchase Agreement (BPA) call under the GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests, with a ceiling value of $80,917.09 and a completion date of April 30, 2022.
Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized biomedical products and services primarily supporting blood banking operations across federal healthcare systems, including the VA, Defense Logistics Agency (DLA), and Department of Health and Human Services (HHS). This contract award, which is not designated as a set-aside, provides the VA with a wide range of essential blood banking products, such as ALBACYTE antibody screening cells, ALBACLONE antibodies, ALBAHANCE additives, and ALBASURE quality control kits, to support diagnostic testing, blood typing, and transfusion services at VA medical facilities.
Quick answers
Who was awarded contract 36C25518N3253?
36C25518N3253 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on June 1, 2018.
How much is contract 36C25518N3253 worth?
The government has obligated $61,508 on 36C25518N3253. Its current value, with exercised options, is $80,917.
Is contract 36C25518N3253 an order under another contract?
Yes. 36C25518N3253 is a BPA call under V797P2050D-VA25515A0029, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25518N3253 competed?
The extent of competition for 36C25518N3253 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award